• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Sanofi-Aventis ADR

Sanofi-Aventis ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. James Dolan's New York sports broadcaster MSG Networks is looking to sell

    James Dolan's New York sports broadcaster MSG Networks is looking to sell

  2. This ETF Delivers a Bundle of S&P 500 Healthcare Stocks at a Reasonable Price

    Health Care Select Sector SPDR boasts a portfolio full of wide-moat names and a competitive price tag.

  3. Funds That Buy Like Buffett 2015

    Funds that emulate the Oracle of Omaha have done well over time.

  4. Low-Cost Exposure to U.S. Healthcare Firms

    This ETF holds a swath of large- and mid-cap U.S. healthcare companies.

  5. Funds That Buy Like Buffett 2015

    Funds that emulate the Oracle of Omaha have done well over time.

  6. Our 2014 Big Pharma Pipeline Rankings: Who Came Out on Top?

    Merck's reinvigorated pipeline and Sanofi's minimal patent-loss exposure placed them atop our rankings this year, while GlaxoSmithKline joined Pfizer toward the bottom.

  7. Top 10 Purchases and Sales from Our Ultimate Stock-Pickers

    A group of top managers remains cautious and commits more capital to traditional defensive sectors, while taking advantage of a rising (and potentially overvalued) market to book some gains.

  8. 5 Wide-Moat Stocks That Were Left Behind in 2014

    It was a good year for wide-moat stocks overall, but Exxon, Amazon, and a few others lagged the market, says Morningstar markets editor Jeremy Glaser.

  9. Prescribe to Pharma for Emerging-Markets Growth

    Many developed-country health-care firms have deep roots in emerging markets and can be a good way to gain exposure, says Morningstar's Damien Conover.

  10. Health Care a Leader in Moat Stocks

    The health-care sector has a higher volume of moat firms compared with other industries, and companies' patent and brand power deliver very strong returns on capital.

12345

©2017 Morningstar Advisor. All right reserved.